6^thInternational Conference on
Neurodegenerative Disorders & Stroke

Dr. Jun Li obtained his Ph.D. from the University of Dublin in Ireland. He then received his post-doctoral training at the University of Connecticut Health Center. In 2009, he secured an Assistant Professor position at the University of Connecticut Health Center with extramural support from the American Heart Association in the form of a national Scientist Development Grant award. He then transitioned to a tenure-track Assistant Professor position after obtaining an R01 and an R21 grants in 2012. Dr. Li joined the Neurology department at UTHealth in 2015 as the Director of Basic Stroke Research. Dr. Li has served on the grant peer review committee for American Heart Association and has been a manuscript reviewer for many high impact international journals. One of Dr. Li’s main areas of interest is to encourage research in students. He has been mentoring medical, pre-med and graduate students for many years in research as a faculty member in the UConn Medical School and here at UTHealth. As an educator, Dr. is additionally enthusiastic about class room teaching and has been teaching courses including neuroanatomy to medical students at UConn and UTHealth.

Cerebral ischemia Dr. Li’s lab aims to identify novel therapeutic approaches to reduce mortality and disability resulting from stroke. Dr. Li’s research currently is funded by the National Institutes of Health (NIH) to investigate the neuroprotective roles of calcium/calmodulin-dependent protein kinase (CaMK) cascade in cerebral ischemia. The lab has been investigating axonal plasticity, neuronal and vascular regeneration, as well as brain functional recovery after cerebral ischemia. Dr. Li also has long-standing interests in the profound impact of biological variable including gender and aging on stroke outcome. His team has extensive experience of in vivo and in vitro stroke models, pharmacology, brain blood flow measurements, brain immune regulation, viral vector transduction, models for neurite plasticity studies and long-term brain functional recovery assessments.

Experienced Assistant Professor with a demonstrated history of working in the hospital & health care industry. Skilled in Emergency Medicine, Public Speaking, Neurosurgery, Healthcare Information Technology (HIT), and Grant Writing. Strong education professional graduated from Medical University/Medical Academy, Sofia.

Vascular Neurosurgery - brain hemorrhage, aneurysm, AVM, ischemic stroke

Prof. Cassandra Szoeke brings together high level management and communication skills with scientific expertise. She led the research program in Neurodegenerative Diseases, Mental Disorders and Brain Health at the Australian Commonwealth Science and Industry Organisation and then became a Clinical Consultant to CSIRO. She has significant experience in governance and formal training including being a graduate of the Australian Institute of Company Directors. Her most recent board appointment was to board of executive directors for the Western Health Service Network employed by the Victorian Minister for Health and in this role she was Chair of both the Quality & Safety and the Education & Research Board sub-committees. She is a practicing physician in internal medicine with subspecialisation in neurology. In addition to her medical qualifications she has an honours degree in Genetics and Pharmacology, and completed her PhD thesis in Epidemiology examining women’s healthy ageing with postdoctoral studies conducted between Stanford University and Duke University focussed on Public Health and Policy. She has been in clinical research for over a decade with more than 100 publications in peer-reviewed journals and is a reviewer for national and international journals and funding bodies. She has been the recipient of numerous national and international awards for her research work and is regularly invited to chair and speak at international and national conferences and has been invited expert to international roundtables and has initiated and been involved in conference organisation and the write-up of conference proceedings. She has held roles on scientific, management and business development committees of several major population-based Australian studies (budgets over 5 million). She is currently the Director of Healthy Ageing Programs at the University of Melbourne (Women’s Healthy Ageing - WHAP) and the Australian Healthy Ageing Organisation.

Neurodegenerative Diseases, Mental Disorders and Brain Health

Dr. Panagos is a Professor of Emergency Medicine and Neurology at Washington University in St Louis. He is a 1987 graduate of Dartmouth College. In 1994, he completed his medical education at Emory University. Following a year of surgical training at Naval Medical Center San Diego, he graduated and received his wings as a Naval Flight Surgeon in Pensacola, Florida. From 1996-1999, he was stationed in Okinawa, Japan from with the 1st Marine Aircraft Wing. In 2002, he completed a residency in Emergency Medicine at the University of Cincinnati and subsequently completed a SAEM funded Neurovascular Emergencies/Stroke Fellowship at the same institution in 2003. This was a first for an emergency physician in the US. Dr. Panagos’ primary research and clinical interest is the acute stroke management. He has published over 100 articles and abstracts and has lectured over 350 times across the US and worldwide, mainly on the topic of stroke care. At Washington University, he has served as the site PI for the IMS III, EXTEND and STOP IT trials-all NIH funded. He is the Director of Neurovascular Emergencies in the Division of Emergency Medicine and Co-Director of the Barnes-Jewish Hospital/Washington University Stroke Network. He currently serves on the ACEP Research Committee, American Stroke Association Scientific Statements Oversight Committee, American Stroke Association Advisory Committee and Chairs both the American Stroke Association Mission: Life Stroke Committee and Comprehensive Stroke Center EMS Routing Subcommittee. He has previously served as Chair of the Emergency Neurovascular Care Committee. He is a reviewer and Editor for several emergency medicine journals in the US and abroad, including Associate Editor of the Academic Emergency Medicine journal. Dr. Panagos is currently a Fellow of both the American Heart Association (AHA) and American College of Emergency Medicine (ACEP).

acute stroke management

Ismail Hakki was born in 1954 in Trabzon. Elementary school Maçka completed middle and high school education in Trabzon. After completing Ataturk University Faculty of Medicine, he started as an assistant at Brain Surgery Department. After continuing his specialization at the Faculty of Medicine of Istanbul University, Department of Neurosurgery, Professor at the Neurosurgery Clinic of Zurich University. Dr. Mahmut Gazi completed his studies on micro neurosurgery beside Yasargil. He served as an Instructor at the Zurich Micro Neurosurgery Research Center, and was also involved in research in Cerebro-vascular microsurgery. He returned to Turkey at the end of 1984 and was appointed to the Presidency of the Department of Neurosurgery at Ataturk University Medical Faculty. In 1985, he first founded the University of Micro Neurosurgery Research Laboratory in Turkey. In addition to Switzerland, he has been researching at different times in Germany, France, England, Austria, Belgium, Holland, Italy, Spain, Yugoslavia, Canada, USA and Japan. In 1988, TUBITAK received the TUBITAK award in 1990 for the first time in the world to develop a new surgical technique used in the operations of brain-artery occlusions, which was literally translated in its own name. In 1991, the United States was awarded the Congress of Neurological Surgeons' INTERNATIONAL FELLOW and FCNS title for his research and contributions to surgical treatment of brain hemorrhages and aneurysms. In the same year, he was awarded by RECTORS and DECISION. AYDIN won the TURKISH NEUROSURGERY RESEARCH AWARD in 1992. The same year, he was elected to the European Stroke Science Council. In the American Stroke Council, he was given the INTERNATIONAL SCIENTIST MAN and FICA DEPARTMENT. In 1992, 1993, 1994 and 1995, he received the US Continuing Medical Education Credit Awards in Neurosurgery. In 1993, he became the first Turkish and first Muslim scientist to enter the Council by electing the Congress of Neurological Surgeons INTERNATIONAL BOARD OF DIRECTORS, as well as members of the Council of Brain Tumors, the Cerebrovascular Surgery Section and many other scientific and administrative boards in the United States. As an invited lecturer, Professor Aydin participated in many international conferences and participated in the publishing boards of scientific journals. He is the OFFICIAL LECTURER of New York Science Academy's Active, AANS 'International Member and 1994 International Skull Base Surgery Congress, was elected to the International Science Council. In 1996, the US received a Neurosurgeon Continuing Education Award with very high credit. With the cause of a research done in 1997, it was COVER to an International Neurosurgical Journal. 1999 received the Turkish Neurosurgery Award. The International Conference of the Year 2000 was selected by the United States Department of Neurosurgery (CNS). Overseas and in our country, many institutions and organizations have been appreciated and rewarded many times. In 2001 in Hidistan, due to the contributions of the Dream Science, it was transformed with CRYSTAL KÃœRE. In 2002 he was invited to Yemen, where he gave many lectures and conferences, and performed educational surgeries. In 2004, she participated in the Pakistan Brain Surgery Congress as a SURF TARGET and gave various conferences. It was abridged here with "ANNUAL AWAR 2004". At international level, more than 200 domestic and foreign scientific studies. Dr. Ismail Almighty Aydin, to this day, many Doctors, Brain Surgeons, Assist. Professor, Associate Professor and Professor. The surgical techniques developed and developed by leading scientists of the world, both abroad and in books and articles, have been included in classical books. Professor AYDIN is also present in the evaluation and decision boards of various scientific organizations besides his duty in Atatürk University Brain Surgery Department. He also works as the President of CNS 'INTERNATIONAL ASSOCIATION AND NERVOUS SYSTEM SURGERY ASSOCIATION in the USA. He is married, has three children, He speaks four foreign languages.

Cerebrovascular and Anatomical Neurosurgery

Scientist with in depth knowledge and hands on experience in stem cell biology and neurodenerative disorders such as Alzheimer's disease and Frontotemporal dementia. Always interested in potential collaborations and new career opportunities. Currently working at Copenhagen University as Associate Professor and Scientific Project Manager for Stemmad, Neurostem and Brainstem. Hands on experience with organizing research amongst different groups all over Europe in order to fulfill milestones and deliverables of several EU and local grants; including periodic and final reporting. My scientific work includes basic research using neurons derived from human induced pluripotent stem cells to develop in vitro disease models and identify novel disease mechanisms as well as overlapping pharmaceutical targets amongst neurodegenerative diseases. As a scientific project manager I am striving to streamline research and collaboration amongst our involved partners, write scientific progress reports and ensure completion of milestones and deliverables.

-Neurodegenerative Diseases - Human, mouse and porcine stem cell biology (adult, embryonic and iPS cells) - Neural differentiation and neurodegenerative disorders (Alzheimer’s disease, Frontotemporal dementia and Huntington's disease) - Pancreas development, specifically analysis of transcription factors in pancreatic cell lineage commitment - Human genetics with a focus on X-linked mental retardation

Dr. Omar is a US Board-Certified Neurologist and Neurological Oncologist. He also has subspecialized training in Endovascular Neurosurgery from the University of Oxford. Dr. Omar's main area of interest is the development of innovative approaches for the management of brain and spinal cord malignancies. He has a unique set of skills that spans across the various disciplines of Neurosciences. He received training in Endovascular Neurosurgery (University of Oxford), Neurological Oncology (University of Toronto), Neurology (University of Missouri - Columbia), Epilepsy / Epilepsy surgery evaluations, EEG, intraoperative monitoring, subdural grids and depth electrode interpretation (Cleveland Clinic Foundation) and Cellular and Molecular Neuroscience (PhD, University of Ottawa). He is a member of the Society for NeuroOncology (SNO), American Medical Association, American Physiological Society (Inactive), The Society for Neuroscience (Inactive) and the American Academy of Neurology (AAN). He is also the recipient of numerous awards including the "Medical Innovator - 2013 Award" from the Sangamon County Medical society for his discovery of a novel molecularly targeted approach for the treatment of spinal cord hemangioblastomas, Excellence Scholarship in Science and Engineering from the University of Ottawa, Prize for Outstanding Achievements from the Ottawa Hospital Foundation and a highly coveted Canadian Institutes of Health Research National Fellowship Award for investigating the role of endogenous neural stem cells in brain repair following ischemic and traumatic brain injury.

Development of innovative approaches for the management of brain and spinal cord malignancies

Dr Torne is among the few super specialists who have been internationally trained in the field of Paediatric Neurology. At present Dr Torne is Head of Department of Neurosciences at Surya Children’s Hospital in Mumbai, India Dr Torne has completed her Fellowship in Paediatric Neurology and Epilepsy from Maharashtra University Health Sciences at Lokmanya Tilak Municipal Hospital and Lokmanya Tilak Municipal Medical College, Mumbai. She has had a brief stint at the University College London Hospital, a premier academic institution cum hospital in the UK. She has been trained in Paediatric Neurology at Birmingham Childrens Hospital where she successfully completed her International Fellowship in Paediatric Neurology, Epilepsy and Neurorehabilitation. To complement her advanced training in Paediatric Neurology she has completed many prestigious International courses like British Paediatric Epilepsy Training Course, British Paediatric Movement disorder Training Course in UK. She has also been trained for Ketogenic diet for drug resistant childhood epilepsies at the Asian Institute of Ketogenic Diet. Dr Torne has many accolades to her name which complements her meticulous and explicate personality. She has to her credit valuable publications in reputed peer reviewed International Journals. She has presented many national and international papers in Cambridge, Birmingham, Italy, France and Hungary. She is affiliated to many International and National Paediatric Neurology and Epilepsy associations. She was honoured by International Bursary from European Paediatric Neurology Society with an opportunity to attend one of the prestigious courses in Paediatric Neuromuscular disorder and Neonatal Neurology at Budapest in Hungary. She was invited to attend the valuable Movement Disorder International Winter School Course by Movement Disorder International society at Catania in Italy. As a feather in her cap she was invited as a Chief Guest in World Congress of Anatomist held in Gadag Institute of Medical Sciences in Karnataka.

She is a recipient of MRCPCH UK, an internationally acclaimed medical qualification. Her research interest is in complex paediatric epilepsies, ketogenic diet and paediatric movement disorder.

Ehud Gazit is an Israeli biochemist, biophysicist and nanotechnologist. He is Professor and the incumbent of the Chair for Biotechnology of Neurodegenerative Diseases at Tel Aviv University. From 2012-2014 he also served as the Chief Scientist of the Israeli Ministry of Science and Technology. In the years 2008-2012 was Tel Aviv University Vice President for Research and Development and Chairman of the board of directors of Ramot Ltd, the technology transfer company of Tel Aviv University. Prior to his appointment as Vice President, Gazit served in different academic and administrative positions at Tel Aviv University, including the Head of The Chemistry-Biology double major track, a member of the University Committee for Appointments and Promotions and a member of the managing board of the Center for Nanoscience and Nanotechnology. Gazit received his B.Sc. (summa cum laude) after completing his studies at the Special Program for Outstanding Students of Tel Aviv University (Currently Adi Lautman program), and Ph.D. (with highest distinction) as a Clore Fellow at the Department of Membrane Research and Biophysics, Weizmann Institute of Science in 1997. For his Ph.D. work, he received the John F. Kennedy Award in 1996. He has been a faculty member at Tel Aviv University since 2000, after completing his postdoctoral studies at Massachusetts Institute of Technology (MIT) where he also had held a visiting appointment (2002–2011). Gazit is or was on the editorial board of several journals including Nanomedicine, PLoS ONE, Amyloid, and Current Chemical Biology. He is a member of the Executive Council of University Ltd., a member of the Public council of the program for implantation of science in government, and a member of the steering committee of Yuval Ne’eman workshop for science, technology and security. He was a member (and chairman from 2008–2011) of executive board, The Interdisciplinary Center for Technology Analysis & Forecasting.

Neurodegenerative Disorders, Nanotechnology & Nanomedicine

I am Assistant Professor at the University of Beira Interior an principal investigator of several research projects that aim to boost brain repair in the context of brain ischemic stroke and in Parkinson’s disease. Main objectives of my research group include: - To identify novel factors and delivery platforms to boost neurogenesis in the context of Parkinson’s disease and stroke: focus on retinoic acid, microRNAs and novel neurotrophic factors; - To understand how neuroinflammation modulates neurogenesis; - To disclose the potential role of progenitor endothelial cells in the repair of vascular function as a means to induce neuroprotection and neurogenesis in the context of brain ischemic stroke.

Brain repair in the context of brain ischemic stroke and in Parkinson’s disease

1. 1991 M.D. (Doctor of Medicine), Shiraz University of Medical Sciences, Iran. Thesis: Brain Electrical Activity Mapping. 2. 1996 Ph.D. in Neuroscience. Faculty of Medicine, Kings College, University of London, UK. Thesis: An electrophysiological study of the effects of lesions of the rat primary somatosensory cortex in cortical reorganization and the fetal cortical transplants. 3. 2001 MRCP (UK) - Membership of the Royal College of Physicians of the United Kingdom. 4. 2005 Certificate of Completion of Specialty Training in Neurology, Postgraduate Medical Education and Training Board, UK. 5. 2005 Cognitive and Movement Disorders, University of Cambridge, UK, and Center for Behavioural and Cognitive Neurology, Northwestern University, Chicago, USA 6. 2006 Clinician-Scientist Fellow, Oxford Centre for Functional MRI, University of Oxford, UK 7. 2010 Clinical Neurophysiology Fellowship, National Hospital for Neurology and Neurosurgery, University College London, UK 8. 2017 FRCP (UK) - Fellow of the Royal College of Physicians of the United Kingdom. Membership of Scientific and Professional Organizations: 1. Fellow of the Royal College of Physicians of the UK 2. Member of Association of British Neurologists 3. Member of Association of European Neuroscientists 4. Member of Human Brain Mapping Organization 5. Member of International Brain Research Organization 6. Member of Iranian Neurology Association 1. 2014- Prof of Neurology and Neuroscience Director, Institute for Medical Science and Technology Shahid Beheshti University 2. Dean, School of Cognitive Science Institute for Research in Fundamental Sciences 3. President Iranian Society for Cognitive Science and Technology

1. Clinical application of Functional Brain Mapping using MRI, MEG, EEG, PET 2. Study of Alzheimer, Parkinson and Multiple Sclerosis using quantitative imaging 3. Cognitive and Behavioural Neurology

Bankole Johnson serves as Chair of the Department of Psychiatry, University of Maryland School of Medicine, and directs the basic science consortium research unit: http://somvweb.som.umaryland.edu/absolutenm/templates/?a=2446&z=41. Previously, Bankole Johnson was Alumni Professor and Chairman of the Dept. of Psychiatry and Neurobehavioral Sciences, Professor of Neuroscience, & Professor of Medicine at the University of Virginia. Bankole Johnson graduated in Medicine from Glasgow University, trained in Psychiatry at the Royal London and Maudsley and Bethlem Royal Hospitals and at the Institute of Psychiatry (University of London) and did studies in neuropsychopharmacology (degree from Glasgow University) on the Medical Research Council unit at Oxford University. In 2004, Bankole Johnson earned his Doctor of Science degree in Medicine from Glasgow University. Bankole Johnson's primary area of research expertise is the psychopharmacology of medications for treating addictions. Bankole Johnson is a licensed physician and board-certified psychiatrist throughout Europe and in the US, and Principal Investigator on NIH-funded research studies utilizing neuroimaging, neuropharmacology, and molecular genetics techniques. Bankole Johnson's clinical expertise is in addiction, biological, and forensic psychiatry. In 2007, Bankole Johnson became a Fellow in the Royal College of Psychiatrists; in 2008, a Distinguished Fellow of the American Psychiatric Association; and in 2010, Bankole Johnson became a Fellow in the American College of Neuropsychopharmacology. Bankole Johnson has over 200 publications (h-index = 46), and has edited three books: Drug Addiction and Its Treatment: Nexus of Neuroscience and Behavior, Handbook of Clinical Alcoholism Treatment, and Addiction Medicine: Science and Practice. Bankole Johnson was featured on the Emmy award-winning HBO documentary, Addiction.

Johnson's primary area of research expertise is the psychopharmacology of medications for treating addictions. Principal Investigator on NIH-funded research studies utilizing neuroimaging, neuropharmacology, and molecular genetics techniques. Bankole Johnson's clinical expertise is in addiction, biological, and forensic psychiatry.

Professional Appointments: Staff neuropsychologist, JFK Johnson Rehabilitation Institute, JFK Medical Center, Edison, New Jersey. Education: • Medical Degree, University of Athens, Greece • Master’s Degree in School Psychology, Trinity University, TX • Ph.D. Degree in Behavioral Medicine/Clinical Health Psychology, University of North Texas, TX • Internship, Child- Adult Neuropsychological and Rehabilitation Services; Eastern Virginia Medical School, VA • Pre-Doctoral Fellowship; Brain Injury, Neuropsychological Assessment- Rehabilitation; NYU Rusk Institute of Rehabilitation, NY • Post-Doctoral Fellowship; Child- Adult Neuropsychological Assessment, Research; JFK Johnson Rehabilitation Institute, Edison, NJ Honors: Suma Cum Laude; Dean's list Undergraduate Research Excellence Scholarship Award; Trinity University; Mortar Board National Honor Society, Senior; Gold Key National Honor Society; Alpha Lambda Delta Honor Society; Blue Key Honor Society; Psi Chi Honor Society; Kappa Delta Pi; Behavioral Medicine Scholarship Award; University of North Texas, Department of Behavioral Medicine Professional Memberships: American Psychological Association, International Neuropsychological Society, New York State Psychological Association, International Hellenic Neuropsychological Rehabilitation Society (founder)

Neurobehavioral Disorders, Traumatic Brain Injury, Epilepsy, Sleep

1. Head of Department- Neurosurgery Company Name- Life Memorial Hospital, Medlife Dates Employed- Feb 2014 – Present Employment Duration- 3 yrs 9 months Location- Bucharest, Romania 2. Head of the Neurosurgery Department Company Name- Clinicco Dates Employed- Aug 2012 – Jan 2014 Employment Duration- 1 yr 6 months Location- Brasov County, Romania 3. Chief de clinique Vascular and skull base fellow Company Name- CHUV Dates Employed- Sep 2009 – Jul 2012 Employment Duration- 2 yrs 11 months Location- Lausanne Area, Switzerland 4. Neurosurgery resident Company Name- Clinical Emergency Hospital Dates Employed- Jan 2004 – Dec 2009 Employment Duration- 6 yrs Location- Cluj County, Romania

Neurosurgery, Microsurgery, Neuroscience

1.Associate Director Company NameNeurovascular Imaging Research Core, UCLA Dates Employed- May 2016– Present Employment Duration- 1 yr 6 months 2. Assistant Professor in Residence Company Name- UCLA Dates Employed- Jul 2015 Employment Duration- 2 yrs 4 months Location- Greater Los Angeles Area Department of Neurology and Computer Science 3. Visiting Assistant Professor Company Name- UCLA Dates Employed- Dec 2012 Employment Duration- 4 yrs 11 months Location- Greater Los Angeles Area

His research is directed to Stroke and traumatic brain injuries (TBI) using brain mapping of imaging and biosignals (MR, CT, X-ray angiography, TCD, and ICP).

Experienced Research Scientist with a demonstrated history of working in the hospital & health care industry. Skilled in Flow Cytometry, Animal Models, Confocal Microscopy, Fluorescence Microscopy, and Genetics. Strong research professional with a Doctor of Philosophy (Ph.D.) focused in Immunology from Baylor College of Medicine.

Role of mitophagy in Lymphocyte memory development, neurodegeneration and mitochondria

Dr. Jackalina M. Van Kampen is currently Director of Preclinical Research at Neurodyn Inc. as well as Adjunct Professor in the Department of Biomedical Science. She came to Neurodyn from the Mayo Clinic College of Medicine where she held the position of Assistant Professor of Molecular Neuroscience. Parkinson’s disease has been the main thrust of her career, beginning with graduate training under the supervision of Dr. A. Jon Stoessl, Director of the Pacific Parkinson’s Research Centre, and continuing through postdoctoral training with Dr. Harold Robertson, Research Director and co-founder of the Brain Repair Centre. She has established a research program focused primarily on neuroprotection and neuronal recovery in models of neurodegenerative disease and currently holds a CIHR grant, studying the neruorestorative potential of adult neurogenesis in a rodent model of Alzheimer’s disease. Dr. Van Kampen has also been working with Neurodyn to develop novel neuroprotective therapies for various neurological conditions, including Parkinson’s disease, Alzheimer’s disease, and ALS.

Translational Research, Bioinformatics, Protein Chemistry, Neurodegeneration, and Molecular Biology

1.Head of department, neurologist Company Name- Neurology Depratment, Dr. Kenessey Albert Hospital Dates Employed- Jun 2012 – Present Employment Duration- 5 yrs 5 months Location- Balassagyarmat, Hungary 2. Neurologist Company Name- Military Hospital, Ministry of Defense Dates Employed- May 2008 – May 2012 Employment Duration- 4 yrs 1 months 3. Neurologist Company Name- National Institute of Neurology and Psychiatry, Hungary Dates Employed- Aug 2002 – May 2008 Employment Duration- 5 yrs 10 months

Neurology & Medicine

Prof. Stavros J.Baloyannis was born in Thessaloniki, Greece. He graduated from the School of Medicine of Aristotelian University of Thessaloniki, Postgraduate training (a) in Neurology in Aristotelian University and Institute of Neurology, Queen Square, London, (b) in Neuropathology in Institute of Neurology, Queen Square, Catholic University of Louvain, University of Pennsylvania, Philadelphia (c) in Neurotology and Neuropathology of Auditory pathway in Harvard University, (d). Neuropathology and Experimental Neurology, University of Pennsylvania, (e) Neuroimmunology, Yale University, New Haven. Research on Blood Brain Barrier in dementias, Blood Brain Barrier in Demyelinating diseases, Mitochondria in Alzheimers disease, Synaptogenesis in vivo and in vitro, Neuronal apoptosis in dementias and demyelinating diseases, Dendritic pathology in dementias, Pathology of Golgi apparatus in dementias. Special interests: Neuroethics, Neurolinguistics, Philosophy of Neurosciences, Application of mathematics in Neurosciences, Neurology and the Art. Member of 56 scientific societies in Greece and abroad. Honorary Member of the Academy of Hellenic Air Forces. President of the Society for the amelioration of the quality of life in chronic neurological diseases. President of the Orthodox Medical Association for support of health and medical education in Africa. He was visiting professor in Tufts University, Democretian University, Aristotelian University, School of Theology, Aristotelian University, School of Philosophy. Author of 28 textbooks on Neurology, Neuropathology, Neuropsychology and of 692 papers, published in Greek and International Journals on Neurology, Neuropathology, Neuroimmunology and Neuroethics. Head of the 1st Department of Neurology, Aristotelian University for 20 years (1992-2011). Emeritus Professor of Neurology, Aristotelian University, Thessaloniki, Greece. Director of Research Institute for Alzheimers disease and frontotemporal dementias. Archon Actuarius of the Ecumenical Patriarchate of Constantinople.

Electron Microscopy and Neuropathology of Alzheimers disease, ageing and degenerative conditions of the central nervous system

Dr. Stella Karantzoulis is the founder of Modern Brain Center, offering modern clinical neuropsychological services to a wide range of individuals with suspected or known disorders of the central nervous system. Dr. Karantzoulis has extensive expertise in diagnosing and managing Alzheimer's disease, Parkinson's, traumatic brain injuries, brain tumors, seizure disorders, and learning disorders at all levels. Dr. Karantzoulis' clinical and research interests focus on the early identification of Alzheimer's disease (e.g., mild cognitive impairment and pre-clinical phases) and the development of novel therapeutic approaches in this population. Her clinical practice specializes in the neuropsychological evaluation of memory disorders, dementia, and other neurobehavioral syndromes (including epilepsy, traumatic brain injury, stroke, brain tumor). She is one of the few board-certified clinical neuropsychologists in New York to offer individualized as well as group-oriented approaches to memory intervention. Dr. Karantzoulis obtained her Masters and Doctorate degrees in Clinical Psychology from York University in Toronto, Ontario, Canada. In 2006, Dr. Karantzoulis completed a pre-doctoral internship at the Icahn School of Medicine at Mount Sinai in New York City in the Department of Rehabilitation Medicine, followed by a 2-year clinical post-doctoral residency in the Department of Neurology, Comprehensive Epilepsy Center, at New York University Langone Medical Center (NYULMC).

Early identification of Alzheimer's disease (e.g., mild cognitive impairment and pre-clinical phases) and the development of novel therapeutic approaches in this population, neuropsychological evaluation of memory disorders, dementia, and other neurobehavioral syndromes (including epilepsy, traumatic brain injury, stroke, brain tumor)

Prof. Harry Steinbusch is appointed as Professor in Cellular Neuroscience at Maastricht University in the Netherlands. He is President of the International Neurotoxicity Society. He is founding editor-in-chief of the Journal of Chemical Neuroanatomy, current i.f. 2.475. He is affiliated with the DGIST in Daegu, Korea; KBSI in Deagon, Korea; USP in Sao Paulo, Brazil; Tohoku University, Sendai, Japan; NIMHANS, Bangalore, India. His research interest is focussed on neurodevelopmental influences towards depression and neurodegenerative diseases studied in animal models approaches to start and prevent neurodegenerative processes. This implies combining a broad range of techniques, i.e. molecular neurobiology, quantitative neuromorphology, animal behavior and epigenetics. He has thus far guided 84 Ph.D. students. He has gathered a total of 475 papers. He has been twice coordinating a Marie Curie Early Stage Training site. Currently. He is coordinator of an Erasmus Mundus + program between 4 Euron universities and 3 universities in Japan. He is affilated on 17 editoriaal board and member of 8 International review committees. His current Hirsch factor is 69 and M-factor is 1.9.

Neurodevelopmental influences towards depression and Neurodegenerative diseases

Dr. Gavin Britz earned his MBBCh at the University of the Witwatersrand School of Medicine, South Africa in 1987. He completed a surgical internship in general surgery and fellowship in general surgery at Johns Hopkins Hospital, Baltimore in 1993 and in 2002 he completed his residency in neurosurgery. During his residency he attended St. George’s Medical School, The University of London, UK and served as a Neurosurgical Registrar and Senior Registrar. After residency, he took a cerebrovascular fellowship in 2002 and an Interventional Neuroradiology Fellowship in 2003 at the University of Washington Medical School, Seattle. In 2003 he earned his MPH at the University of Washington, Seattle. He also obtained an MBA from George Washington University in 2015. He held faculty appointments at the University of Washington and Duke University before becoming a member of Houston Methodist Research Institute in 2014.

Brain aneurysm, cerebral microcirculation, acute brain injury & evaluating new and novel tools to treat a wide variety of problems such as brain aneurysms and skull base tumors

1.Chair of Neurosurgery department Company Name-Caddi Ayyad university medical school Dates Employed-Jan 2001 – Present Employment Duration-16 yrs 9 mos Location-Préfecture de Marrakech, Morocco 2. Director of Neurosurgery program Company Name University Hospital center of Marrakesh & University Medical School Dates Employed-Jan 2001 – Present Employment Duration-16 yrs 9 months Location-Préfecture de Marrakech, Morocco 3. Chairman of the ethic committee Company Name-Mohammed VI University Hospital Center And Cadi Ayyad University Medical School Dates Employed-Jan 2015 – Present Employment Duration-2 yrs 9 months Location-Préfecture de Marrakech, Morocco 4.Full Professor of Neurosurgery. Company Name-Cadi Ayyad University Medical School Dates Employed-Jan 2004 – Present Employment Duration-13 yrs 9 mos Location-Préfecture de Marrakech, Morocco 5. Head of Department of Neurosugery Company Name-Mohammed VI University Hospital center of Marrakesh Dates Employed-Sep 2000 – Present Employment Duration-17 yrs 1 mo Location-Préfecture de Marrakech, Morocco 6. Vice Dean of Research Company Name-Université Cadi Ayyad Marrakech Dates Employed-Jan 2003 – Dec 2005 Employment Duration-3 yrs Location-Préfecture de Marrakech, Morocco

Neurosurgery

1. Chair-Croatian Institute for Brain Research · Dept. Neuroscience · Laboratory for Developmental Neuropathology Croatia · Zagreb 2. Prof. of Neuroscience and Anatomy Company Name-Croatian Institute for Brain Research, School of Medicine, University of Zagreb Dates Employed-Oct 2011 – Present Employment Duration-6 yrs Location-Zagreb Education University of Zagreb Degree Name- M.D. Field Of Study Medicine Dates attended or expected graduation 1986 – 1992

Neuroscience,Developmental Neuropathology,Neurological diseases, Brain, Neurodegeneration, Brain Computer Interfaces, fMRI

For 25+ years my research has been centered on the mechanisms of experimental stroke, particularly on the role of the immune system and neurovascular changes in injury and repair after stroke. It has become clear that arterial ischemic stroke is as common in human neonates as in ageing adults and that it produces significant morbidity and severe long-term neurological and cognitive deficits, including cerebral palsy and neurodevelopmental disabilities. My lab was the first to establish focal stroke models in neonatal rats and mice. We discovered a strikingly better preserved blood-brain barrier integrity after acute neonatal stroke than after adult stroke. We then discovered that microglial cells serve as endogenous neuroprotectants following neonatal stroke. We are investigating the contribution of microglial-extracellular matrix interactions and lipid signaling in injury and repair after stroke. At UCSF I have served as the Director of Research, Neonatal Brain Disorders Center, since 2003. I have served on the NIH study sections and chaired several Brain Committees for the AHA.

Role of the immune system and Neurovascular changes in injury and repair after stroke, Brain Disorders

Dr. F. N.Kautzmann III is President, CEO, Chairman and Executive Director of Real Data Inc.org which is located in the USA. Before joining Real Data Inc.org Dr. F.N. Kautzmann III has held superior positions with MITRE Corporation, NASA-JSC. He earned several Ph.D.'s from Universities in different subjects, to name few- Three Ph.D.'s in Analytic Philosophy and Pure Mathematics, Number Theory, and a Ph.D. in Theoretical Computer Science, Columbia. He a Litt.D. from Cambridge. He is an Elected Fellow in fifteen UK scholarly Societies, has been an Adjunct Professor at Rice University and the University of Houston, Ph.D. programs.

Analytic/Continental Philosophy, Pure Mathematics, Number Theory, Theoretical Computer Science, Philosophy of Science, Evolutionary Biology, Genetics and Medicine.

1. Director of Cerebrovascular Research Laboratory Company Name- The Houston Methodist Hospital, Department of Neurosurgery Dates Employed- Oct 2013 – Present Employment Duration- 4 yrs Location- Houston, Texas Area 2. Director of Research, Department of Neurosurgery Company Name- North Shore-LIJ Health System/Feinstein Institute for Medical Research Dates Employed- Feb 2012 – Sep 2013 Employment Duration- 1 yr 8 months Location- Greater New York City Area 3. Research Professor of Neurosurgery Company Name- Institute of Academic Medicine at Houston Methodist Hospital Dates Employed- Jun 2014 – Present Employment Duration- 3 yrs 4 mos Location- Houston, Texas Area 4. Program Director, stroke, cerebral blood flow Company Name- NINDS/NIH Dates Employed- Jan 2006 – Sep 2009 Employment Duration- 3 yrs 9 mos

Stroke, Neurosurgery, cerebral Blood Flow

Professor Company Name- University of Colorado Health Sciences Center Dates Employed- Sep 1999 – Present Employment Duration- 18 yrs 1 mo Location- Aurora, Colorado Pharmaceutical outcomes, comparative effectiveness research in disease areas that include multiple sclerosis, hepatitis C, prostate cancer, auto-immune disorders utilizing pragmatic and observational studies; secondary data sources from health plans EMR data, clinically observed data, patient reported data imagjng MRI based data, national data sets, literature based evidence and triangulating various sources of data. Outcomes researcher and Professor of Neurology and Pharmacy at the University of Colorado, Anschutz Medical Campus primarily in the area of Multiple Sclerosis- Rocky Mountain MS Center) in the Department of Neurology. Additionally, outcomes researcher in the area of Hepatitis C with the Department of Hepatology (University of Colorado AMC campus), Denver Health and Project ECHO-Colorado.

Comparative Effectiveness Research (CER) in Multiple Sclerosis to include triangulating brain atrophy, clinically observed and patient reported measures between DMT.